Eritoran Tetrasodium
Eritoran Tetrasodium is a synthetic TLR4 antagonist investigated for its therapeutic potential in type 2 diabetes research. Studies in vitro and in vivo models explore its role in modulating inflammation-linked insulin resistance and metabolic dysfunction.
Product Specifications
CAS Number
185954-98-7
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Smiles
[Na].CCCCCCCCCCCC (=O) CC (=O) N[C@H]1[C@@H] (OP (O) (O) =O) O[C@H] (CO[C@@H]2O[C@H] (COC) [C@@H] (OP (O) (O) =O) [C@H] (OCC[C@@H] (CCCCCCC) OC) [C@H]2NC (=O) CCCCCCCCC\C=C/CCCCCC) [C@@H] (O) [C@@H]1OCCCCCCCCCC
Molecular Formula
C66H122N2Na4O19P2
Molecular Weight
1401.58
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AU2044-01 1 Kit
Fluorescent Universal Human IgG/IgM Lateral Flow Serology Kit (Qdot)
Sign In for Pricing
View Details